6BJR image
Entry Detail
PDB ID:
6BJR
Keywords:
Title:
Crystal structure of prothrombin mutant S101C/A470C
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2017-11-06
Release Date:
2018-06-27
Method Details:
Experimental Method:
Resolution:
6.00 Å
R-Value Free:
0.29
R-Value Work:
0.23
R-Value Observed:
0.23
Space Group:
C 2 2 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Prothrombin
Mutations:S101C, A470C
Chain IDs:A
Chain Length:582
Number of Molecules:1
Biological Source:Homo sapiens
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
CGU A GLU modified residue
Primary Citation
Structure of prothrombin in the closed form reveals new details on the mechanism of activation.
Sci Rep 8 2945 2945 (2018)
PMID: 29440720 DOI: 10.1038/s41598-018-21304-1

Abstact

The clotting factor prothrombin exists in equilibrium between closed and open conformations, but the physiological role of these forms remains unclear. As for other allosteric proteins, elucidation of the linkage between molecular transitions and function is facilitated by reagents stabilized in each of the alternative conformations. The open form of prothrombin has been characterized structurally, but little is known about the architecture of the closed form that predominates in solution under physiological conditions. Using X-ray crystallography and single-molecule FRET, we characterize a prothrombin construct locked in the closed conformation through an engineered disulfide bond. The construct: (i) provides structural validation of the intramolecular collapse of kringle-1 onto the protease domain reported recently; (ii) documents the critical role of the linker connecting kringle-1 to kringle-2 in stabilizing the closed form; and (iii) reveals novel mechanisms to shift the equilibrium toward the open conformation. Together with functional studies, our findings define the role of closed and open conformations in the conversion of prothrombin to thrombin and establish a molecular framework for prothrombin activation that rationalizes existing phenotypes associated with prothrombin mutations and points to new strategies for therapeutic intervention.

Legend

Protein

Chemical

Disease

Primary Citation of related structures